Home LiteratureArticle Details
PMID: 8107262 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus.

Journal of virology ·Vol. 68 ·No. 3 ·1994-03-00 ·Pages 1998-2001

Mancuso VA, Hope TJ, Zhu L, Derse D, Phillips T, Parslow TG

Abstract

By systematically dissecting the Rev proteins of feline immunodeficiency virus (FIV) and equine infectious anemia virus (EIAV), we have identified within each a short peptide that is functionally interchangeable with the effector domains found in Rev-like proteins from other retroviruses. The active sequences from FIV and EIAV differ in several respects from other known effectors and may represent a distinct class of effector domain.

MeSH Terms
Amino Acid Sequence DNA Mutational Analysis Gene Products, rev/genetics,pharmacology Immunodeficiency Virus, Feline/genetics Infectious Anemia Virus, Equine/genetics Molecular Sequence Data RNA Processing, Post-Transcriptional/drug effects Recombinant Proteins/pharmacology Sequence Homology, Amino Acid Structure-Activity Relationship
Chemicals
Gene Products, rev Recombinant Proteins
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Mancuso V A
Department of Pathology, University of California, San Francisco 94143-0506.
Hope T J
Zhu L
Derse D
Phillips T
Parslow T G
References (22)
22 references, click to expand
  1. Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein.
    Nature. 1988 Oct 20;335(6192):738-40 PMID: 3262832
  2. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus.
    J Virol. 1992 Sep;66(9):5464-71 PMID: 1323707
  3. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.
    Proc Natl Acad Sci U S A. 1989 Mar;86(5):1495-9 PMID: 2784208
  4. Regulation of human immunodeficiency virus env expression by the rev gene product.
    J Virol. 1989 May;63(5):1959-66 PMID: 2704072
  5. Structural and functional characterization of the human immunodeficiency virus rev protein.
    J Acquir Immune Defic Syndr. 1989;2(3):256-63 PMID: 2656990
  6. Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function.
    Cell. 1989 Jul 14;58(1):205-14 PMID: 2752419
  7. Trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I Rex transactivator.
    Nature. 1989 Oct 5;341(6241):453-6 PMID: 2677743
  8. Regulation by HIV Rev depends upon recognition of splice sites.
    Cell. 1989 Dec 1;59(5):789-95 PMID: 2686839
  9. Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells.
    Nucleic Acids Res. 1990 Apr 25;18(8):2037-44 PMID: 2186373
  10. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.
    J Virol. 1990 Aug;64(8):3716-25 PMID: 2164593
  11. Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus.
    J Virol. 1990 Nov;64(11):5360-6 PMID: 2120472
  12. U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7598-602 PMID: 2217190
  13. Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7787-91 PMID: 2217212
  14. Human immunodeficiency virus as a prototypic complex retrovirus.
    J Virol. 1991 Mar;65(3):1053-6 PMID: 1995941
  15. Minimal Rev-response element for type 1 human immunodeficiency virus.
    J Virol. 1991 Apr;65(4):2131-4 PMID: 2002556
  16. Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins.
    J Virol. 1991 Jul;65(7):3877-81 PMID: 1645796
  17. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain.
    J Virol. 1991 Aug;65(8):4248-54 PMID: 2072452
  18. Identification of feline immunodeficiency virus rev gene activity.
    J Virol. 1991 Aug;65(8):4539-42 PMID: 1649349
  19. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif.
    Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7734-8 PMID: 1715576
  20. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev.
    Cell. 1991 Oct 4;67(1):169-78 PMID: 1913815
  21. Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif.
    J Virol. 1991 Nov;65(11):6001-7 PMID: 1920623
  22. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.
    Nature. 1989 Mar 16;338(6212):254-7 PMID: 2784194
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1994-03-00
Pages
1998-2001
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC236666
Subset
IM
Grants
NIAID NIH HHS · AI29313 · United States
NIGMS NIH HHS · GM43574 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com